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Streptococcus pneumoniae produces two surface-associated lipoproteins that share homology
with two distinct families of peptidyl-prolyl isomerases (PPIases), the streptococcal lipoprotein
rotamase A (SlrA) and the putative proteinase maturation protein A (PpmA). Previously, we have
demonstrated that SlrA has PPIase activity, and that the enzyme plays a role in pneumococcal
virulence. Here, we investigated the contribution of PpmA to pneumococcal pathogenesis.
Pneumococcal mutants of D39 and TIGR4 lacking the gene encoding PpmA were less capable of
persisting in the nasopharynx of mice, demonstrating the contribution of PpmA to pneumococcal
colonization. This observation was partially confirmed in vitro, as the pneumococcal mutants
NCTC10319DppmA and TIGR4DcpsDppmA, but not D39DcpsDppmA, were impaired in
adherence to Detroit 562 pharyngeal cells. This suggests that the contribution of PpmA to
pneumococcal colonization is not solely the result of its role in adherence to epithelial cells.
Deficiency in PpmA did not result in reduced binding to various extracellular matrix and serum
proteins. Similar to SlrA, we observed that PpmA was involved in immune evasion. Uptake of
PpmA-deficient D39Dcps and NCTC10319 by human polymorphonuclear leukocytes was
significantly enhanced compared to the isogenic wild-types. In addition, ingestion of D39DppmA,
but not that of either NCTC10319DppmA or TIGR4DppmA, by murine macrophage cell line J774
was also enhanced, whereas intracellular killing remained unaffected. We conclude that PpmA
contributes to the early stages of infection, i.e. colonization. The contribution of PpmA to virulence
can be explained by its strain-specific role in adherence to epithelial cells and contribution to the
evasion of phagocytosis.
INTRODUCTION
Streptococcus pneumoniae resides in the nasopharyngeal
cavity of the human host. Pneumococcal carriage is
regarded as the key linking transmission of this Gram-
positive bacterium to other susceptible individuals, but is
also considered to be a prerequisite for disease. Although
colonization is usually asymptomatic, it can progress to
disease when colonizing S. pneumoniae infiltrate the middle
ear, lungs, brain or blood. Consequently, this pathogen is a
major cause of morbidity and mortality worldwide,
especially in young children, the elderly and immunocom-
promised individuals (Bogaert et al., 2004).
Multiple bacterial factors are required for colonization and
infection of the host to occur. For instance, the expression
of capsule reduces entrapment in the luminal mucus,
allowing the pneumococci access to epithelial surfaces
(Nelson et al., 2007). Inside the host, this polysaccharide
capsule serves as a biochemical barrier, protecting the
pneumococcus from phagocytosis and killing by inhibiting
complement deposition and consequently complement
activation (Hammerschmidt et al., 2005). Several bacterial
adhesins are involved in adherence to the epithelial surface,
including phosphorylcholine (ChoP), which interacts with
the receptor for platelet-activating factor (rPAF) (Cundell
et al., 1995; Swords et al., 2000). In addition, ChoP serves
as a non-covalent anchor for a group of surface proteins
known as the choline-binding proteins. Of these, PspC
(also referred to as CbpA or SpsA), binds to human
secretory component (SC) of the polymeric Ig receptor
Abbreviations: CI, competitive index; FCS, fetal calf serum; hpIgR,
human polymeric immunoglobulin receptor; PMN, polymorphonuclear
leukocyte; PPIase, peptidyl-prolyl isomerase.
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during the first stage of translocation across the epithelium
(Elm et al., 2004; Hammerschmidt, 2006; Zhang et al.,
2000).
In addition to the surface components directly involved in
adhesion and immune invasion, factors influencing proper
protein folding and surface composition are also essential
for bacterial virulence. Peptidyl-prolyl isomerases (PPIases)
are ubiquitous foldases, which accelerate the cis–trans
conformational changes at the Xaa-Pro bonds during
protein folding (Hermans et al., 2006; Rahfeld et al., 1994).
They are classified into three separate families, i.e. the
parvulins, the FK506-binding proteins (FKBP) and the
cyclophilins. The parvulins are the smallest known proteins
with PPIase activity, and have a lower relative activity
against biological substrates than the cyclophilins and the
FK506-binding proteins. PPIases have been identified in
both eukaryotes and prokaryotes. For example, SurA is a
parvulin located in the periplasm of Escherichia coli which
has a role in the assembly of outer-membrane proteins of
Gram-negative bacteria (Lazar & Kolter, 1996; Rouviere &
Gross, 1996). Another parvulin is PrsA, which is a
membrane-bound lipoprotein known to be involved in
the protein export and maturation machinery of Gram-
positive bacteria (Vitikainen et al., 2004). The product of a
prsA-like gene from Lactococcus lactis, PmpA, is thought to
possess foldase activity facilitating protein secretion
(Drouault et al., 2002). Several studies have also indicated
a role for PPIases in virulence. For instance, the trigger
factor of Streptococcus pyogenes is considered to be
responsible for the secretion of many virulence factors
(Lyon et al., 1998). The macrophage infectivity potentiator
(Mip) protein of Legionella pneumophila belongs to the
FKBPs and is required for entry into human alveolar
macrophages and intracellular replication of this Gram-
negative micro-organism (Cianciotto et al., 1989;
Cianciotto & Fields, 1992).
The pneumococcal genome contains four putative PPIases,
two of which are produced as surface-associated lipopro-
teins: the streptococcal lipoprotein rotamase A (SlrA) and
the putative proteinase maturation protein A (PpmA). In a
previous study, we demonstrated that SlrA is a functional
cyclophilin-type PPIase involved in pneumococcal col-
onization, as slrA mutants are rapidly eliminated from the
upper airways in a mouse pneumonia model. In addition,
we provided evidence that a deficiency in SlrA substantially
reduces adherence to and internalization by epithelial and
endothelial cells (Hermans et al., 2006).
PpmA is the second surface-associated PPIase, and is
abundantly produced and conserved among pneumococci.
It has homology to the parvulin family of proteins, but no
detectable PPIase activity has been found to date (Hermans
et al., 2006; Overweg et al., 2000a). It was previously shown
that ppmA-deficient mutants display reduced virulence in a
mouse pneumonia model (Overweg et al., 2000a). In the
current study, we investigated the role of PpmA in
pneumococcal virulence in more detail. We show here
that PpmA contributes to pneumococcal colonization of
the murine nasopharynx. Furthermore, we demonstrate
that PpmA is involved in in vitro adherence to epithelial
cells and that expression of PpmA interferes with uptake by
professional phagocytes.
METHODS
Pneumococcal strains and growth conditions. Pneumococcal
strains used in this study are shown in Table 1. S. pneumoniae was
routinely grown in Todd–Hewitt broth supplemented with 5 g yeast
extract l21 (THY) or on Columbia blood agar (BA) plates (Oxoid) at
37 uC and 5% CO2. The number of c.f.u. per millilitre in a particular
sample was quantified by plating serial 10-fold dilutions on BA plates.
When indicated, antibiotics were used at the following concentra-
tions: kanamycin, 250 mg ml21, trimethoprim, 25 mg ml21 and
streptomycin 100 mg ml21.
Construction of pneumococcal mutants. The D39DppmA and
NCTC10319DppmA mutants were constructed by in-frame insertion
deletion mutagenesis using the trimethoprim resistance cassette,
dfr13, as described previously (Hermans et al., 2006). To obtain the
Table 1. Bacterial strains and mutants used in this study
Strain Serotype Antibiotic resistance Reference
D39 wild-type 2 NCTC 7466
D39 : : rpsL 2 Streptomycin This study
D39DppmA 2 Trimethoprim Hermans et al. (2006)
D39Dcps – Kanamycin This study
D39DppmADcps – Trimethoprim, kanamycin This study
NCTC10319 wild-type 35A Hermans et al. (2006)
NCTC10319 : : rpsL 35A Streptomycin This study
NCTC10319DppmA 35A Trimethoprim Hermans et al. (2006)
TIGR4 wild-type 4 Tettelin et al. (2001)
TIGR4 : : rpsL 4 Streptomycin This study
TIGR4DppmA 4 Trimethoprim This study
TIGR4Dcps – Kanamycin This study
TIGR4DppmADcps – Trimethoprim, kanamycin This study
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TIGR4DppmA strain, a DppmA-PCR product was amplified from
D39DppmA with primer pair HBppmAF1 (59-CTCTTGAT-
GGCTGAACATGC-39) and HBppmAR1 (59-GCAGCCTACAG-
CTAGCTTCC-39). This PCR product was introduced into TIGR4
by transformation, and trimethoprim-resistant colonies were checked
for the ppmA mutation by PCR.
The isogenic capsule locus (cps) deletion mutants were constructed by
allelic replacement of the entire capsule gene cluster with the
kanamycin resistance cassette of plasmid pR410 (Burghout et al.,
2007) as follows. Primers HBdexBF3 (59-TATCAGGAAGGT-
CAGCCTAA-39) and HBdexBR2_F4 (59-TAAGCTTGATATCGAA-
TTCCTGCACTAAGGACACGCTTCT-39), and HBaliAF_R (59-GG-
ATGAATTGTTTTAGTACCTGACGCGCTTACGATATTCA-39) and
HBaliAR (59-TTTCGCAAATTCAACAGAGG-39), were used to gen-
erate PCR products of the left (dexB) and right (aliA) flanking regions
of the cps locus (approx. 900 bp each). These PCR products were
fused to the kanamycin resistance gene amplified with primers
HBkanF4 (59-GGAATTCGATATCAAGCTTA-39) and HBkanR (59-
AGGTACTAAAACAATTCATCC-39) by means of overlap extension
PCR. The resulting PCR product was transformed into S. pneumo-
niae, and kanamycin-resistant transformants were checked for the
presence of the cps deletion by PCR. The DppmADcps double mutants
were constructed by transformation of the Dcps-PCR product
(amplified with primer pair HBdexBF3 and HBaliAR) to each
DppmA mutant and selecting for trimethoprim and kanamycin
resistance. Resulting transformants were checked for the ppmA and
cps deletions by PCR.
To obtain the streptomycin-resistant D39 : : rpsL, NCTC10319 : : rpsL
and TIGR4 : : rpsL strains, the rpsL gene encoding a streptomycin-
resistant mutant of the ribosomal protein S12 was amplified from
D39 : : rpsL (Hermans et al., 2006) with primer pair HBrpsLF
(59-GTACAGGGACGTGCTGACAA-39) and HBrpsLR (59-
CCCTTTCCTTATGCTTTTGG-39). This PCR product was intro-
duced into D39, NCTC10319 and TIGR4 by transformation, and
streptomycin-resistant transformants were checked for the rpsL
mutation by sequence analysis.
Mouse colonization model: single infection. Prior to mouse
infection experiments, bacteria were passaged in mice to maintain
virulence as described previously (Kerr et al., 2004). Cultures of
mouse-passaged S. pneumoniae strains were grown to an OD620 of
0.25 and stored in aliquots at 280 uC in 15% glycerol. Prior to
infection, aliquots of bacteria were spun down and were resuspended
in sterile PBS. In the colonization model, female 8-week-old CD-1
mice were lightly anaesthetized with 2.5% (v/v) isoflurane over
oxygen (1.5 l min21). Ten microlitres containing 56106 c.f.u. of
bacteria was distributed over both nostrils while the mice were held
vertically by the scruff of the neck. Because such a low volume is
given, only the nasopharynx of the mice becomes infected. Groups of
five or six mice were sacrificed at 0.5, 24, 48, 96 and 192 h post-
infection. Bacteria were recovered from the nasopharynx by flushing
each nare with 1 ml sterile PBS (Hendriksen et al., 2008) and plated
for c.f.u. count. In addition, the lungs from each mouse were removed
from the body, homogenized in 2 ml sterile PBS using a hand-held
homogenizer (Polytron PT 1200, Kinematica AG), and plated. The
30 min time point is considered to be the start of the infection, and is
therefore referred to as t50.
Mouse colonization model: co-infection. For the co-infection, a
10 ml inoculum containing a 1 : 1 ratio of streptomycin-resistant wild-
type and trimethoprim-resistant ppmA mutants (56106 c.f.u. total)
was used to infect female 8-week-old CD-1 mice intranasally as
described above. This model reduces variation between individual
mice, inoculation preparation and distribution, and sample collec-
tion. Groups of five or six mice were sacrificed at 0.5, 24, 48, 96 and
192 h post-infection. Samples from nasopharynx and lungs were
collected as described above. Again, the 30 min time point is
considered to be the start of the infection, and is therefore referred to
as t50. Bacteria recovered from the nasopharynx were plated onto BA
plates and Columbia agar plates supplemented with 5% (v/v)
defribrinated sheep blood (Biotrading) containing either streptomy-
cin or trimethoprim to determine c.f.u. counts. Competitive index
(CI) scores were calculated for the co-infection experiments as
previously described (Hava & Camilli, 2002). In short, a CI score was
obtained by dividing the output ratio of the c.f.u. counts of mutant to
wild-type by the input ratio of mutant to wild-type bacteria. For
experiments in which no mutant bacteria were recovered from a
particular mouse, the lower limit of detection (i.e. 20 c.f.u. ml21) was
substituted as the numerator. A CI score of 1 indicates no change in
the ratio of wild-type and mutant before and after infection. Values
lower than 1 indicate that the mutant is out-competed by the wild-
type strain. All experiments were performed with approval of the
Animal Experimentation Committee (DEC) of the Radboud
University Nijmegen Medical Centre.
Cell lines and cell culture. The human pharyngeal epithelial cell
line Detroit 562 (ATCC number CCL-138) was routinely grown in
RPMI 1640 medium without phenol red (Invitrogen) supplemented
with 1 mM sodium pyruvate and 10% (v/v) fetal calf serum (FCS).
The murine macrophage-like cell line J774 (ATCC TIB 67) was
cultured in Dulbecco’s modified Eagle’s medium (DMEM, PAA
Laboratories) supplemented with 10% FCS, 2 mM glutamine,
penicillin G (100 IU ml21) and streptomycin (100 mg ml21). All
cells were cultured at 37 uC in a 5% CO2 environment.
Adherence assay. For adherence assays, bacteria were grown to
mid-exponential phase in THY and stored in 1 ml aliquots at 280 uC
in THY containing 15% glycerol. Before each assay, bacteria were
resuspended in RPMI 1640 medium without phenol red supplemen-
ted with 1% FCS. Adherence of pneumococci to epithelial cells was
performed as described previously (Bootsma et al., 2007; Hermans et
al., 2006). Briefly, Detroit 562 cells were seeded into 24-well plates
and incubated for 48 h. Confluent monolayers were washed twice
with PBS and infected with 16107 c.f.u. ml21 (m.o.i. of 10 bacteria
per cell) and pneumococci were allowed to adhere to the cells for 2 h
at 37 uC in a 5% CO2 environment. Non-adherent bacteria were
removed by three 1 ml washes with PBS, after which 200 ml of 25%
trypsin and 1 mM EDTA was added to detach the cells, followed by
800 ml of ice-cold 0.025% Triton X-100 in PBS to lyse the cells.
Samples were plated for c.f.u. count, and corrected to account for
small differences in the initial inoculum count. All experiments were
performed in triplicate and repeated at least three times. The
adherence of the mutants is given as the percentage relative to the
wild-type. Wild-type and mutant strains grew comparably in RPMI
medium (without phenol red supplemented with 1% FCS) alone.
Binding of pneumococci to immobilized host proteins and
extracellular matrix. Human factors such as laminin, fibronectin,
fibrinogen, lactoferrin, type IV collagen, plasminogen, serum IgA,
human secretory component and reconstituted basement membrane
(Matrigel; BD Biosciences) were used to coat 96-well plates and kept
overnight at 4 uC. The proteins were purchased from commercial
suppliers (Calbiochem, Sigma and Roche). The surface of the wells
was then blocked with 1% BSA for at least 3 h at room temperature.
Labelling of the bacteria with FITC was performed as described by
Bergmann et al. (2003). Extensively washed FITC-labelled wild-type
or ppmA-deficient pneumococci (2.56107) were added to the wells
and incubated for 1 h at 37 uC to allow binding. Fluorescence was
measured at 485/538 nm (excitation/emission) using a Fluoroskan
Ascent (ThermoLabsystems). Binding is expressed as the percentage
of the total applied FITC-labelled pneumococci bound to the
immobilized proteins. Values are from a representative experiment
PpmA of Streptococcus pneumoniae
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and are the mean of triplicates. Each experiment was performed at
least three times with similar results.
Phagocytosis of bacteria by granulocytes. Human polymorpho-
nuclear leukocytes (PMNs) were isolated from peripheral blood of
four healthy volunteers. Equal volumes of blood and PBS were mixed,
layered on a Ficoll-Histopaque gradient, and centrifuged for 20 min
at 800 g. The isolated phase containing PMN cells was depleted of
erythrocytes by two consecutive hypotonic shocks (Jansen et al.,
1998). Finally, the PMNs were resuspended in RPMI 1640 (PAA
Laboratories) and immediately used for the phagocytosis assay. PMNs
were incubated at a density of 66105 ml21 for 30 min in 50 ml RPMI
1640/1% FCS with FITC-labelled S. pneumoniae at an m.o.i. of 50 at
37 uC. The attachment to PMNs and the uptake of pneumococci by
phagocytosis was stopped by centrifugation. The PMNs were fixed
with 200 ml PBS/1% FBS/1% paraformaldehyde. Binding and uptake
of FITC-labelled bacteria were assessed by flow cytometry using a
FACSCanto (Becton Dickinson). The mean fluorescence intensity
(MFI) of the entire PMN population was recorded as a measure of
bacterial binding and/or uptake. All experiments were performed
independently three times.
J774 internalization assay. The number of viable intracellular
pneumococci after phagocytosis by murine J744 macrophages was
quantified by the antibiotic protection assay as described previously
(Hermans et al., 2006). Briefly, the J774 cells were seeded in a 96-well
format at a density of 16105 per well. All bacterial suspensions were
washed with PBS and diluted in a defined concentration in RPMI
1640, 1% FCS medium. The confluent monolayers were then
inoculated at an m.o.i. of 50. To synchronize the assay, the plates
were centrifuged at 100 g for 4 min. The number of c.f.u. inoculated
per well was quantified by plating on BA plates. After 30 min of
infection, the wells were washed four times with PBS to remove
unbound pneumococci. To kill any extracellular bacteria, an
incubation step with 1 ml per well of DMEM (4.5 g glucose l21)
and 1% FCS (no HEPES) containing gentamicin (100 mg ml21) and
penicillin G (100 IU ml21) was carried out for 1 h. Intracellular
pneumococci were recovered after three washes with DMEM by
saponin-mediated lysis (1% w/v) for 10 min at 37 uC in 5% CO2,
and samples were plated for c.f.u. count. To differentiate between
uptake and intracellular survival, time kinetic experiments were
carried out as follows. Monolayers were infected for 30 min and then
treated with gentamicin and penicillin G as described above. After
removal of the antibiotics by washing, fresh medium was added, and
the plate was incubated for 1, 2 and 3 h. Intracellular pneumococci
were recovered by saponin-mediated lysis, and samples were plated
for c.f.u. count. All experiments were performed at least in triplicate.
Statistical analysis. Comparisons of bacterial loads between wild-
type and mutant bacterial strains were performed using Student’s t-
test (unpaired) for all in vitro assays and with the single infection of
the colonization model. For the co-infection, a one sample t-test
(with an arbitrary mean of 1) was used to calculate statistical
significance for the CI scores. All statistical analyses were performed
using GraphPad Prism version 4.0.
RESULTS
Contribution of PpmA to pneumococcal
colonization in vivo
To assess the contribution of PpmA to pneumococcal
virulence, we inactivated the ppmA gene in the D39,
NCTC10319 and TIGR4 strains using insertion deletion
mutagenesis. Immunoblot analysis of wild-type and ppmA
mutant cell lysates using anti-PpmA rabbit serum showed
that PpmA was expressed in all wild-type strains, but not in
generated mutants (data not shown). To examine the role
of PpmA in colonization, both single and co-infections of
wild-type and DppmA mutant pneumococci were carried
out using the murine colonization model. In this model,
extended colonization of the nasopharynx is achieved by
using a low volume (10 ml) of inoculum. Some infection in
the lungs was seen at the earlier time points, but,
importantly, mice did not show any signs of invasive
disease, and no mice died during the course of the
experiment. After 192 h, the D39 and TIGR4 wild-type
strains colonized the nasopharynx at higher levels (400–
1000 times, respectively) than the NCTC10319 strain. A
significant decrease in bacterial load of the nasopharynx
was seen at 24 h post-infection and onwards with the
D39DppmA mutant compared to its wild-type (Fig. 1a). By
192 h, all six mice infected with D39DppmA had cleared
the infection. Similar to D39DppmA, TIGR4DppmA-
infected mice had significant decreases in bacterial load
after 48 h post-infection (Fig. 1b). Decrease in colonization
with the NCTC10319DppmA mutant compared to its wild-
type was seen as well, albeit only statistically significant in
two out of six time points (Fig. 1c).
To validate the previous findings, we performed co-
infections with each wild-type and its respective mutant
over a period of 8 days. Again, overall colonization levels
of the NCTC10319 wild-type were significantly lower
than those of D39 and TIGR4 wild-type strains. In fact,
the mice had cleared the infection caused by NCTC10319
wild-type and ppmA mutant at 192 h post-infection in
four out of six mice. Results of co-infection experiments
confirmed the decreased ability of D39DppmA to
colonize the nasopharynx, up to 60% less by the 192 h
time point (Fig. 2a). Likewise, the TIGR4DppmA showed
also a reduced colonization efficiency, at 192 h post-
infection (35%; Fig. 2b), while the NCTC10319 wild-
type was unable to out-compete its isogenic ppmA
mutant (Fig. 2c).
Contribution of PpmA to pneumococcal
adherence in vitro
To assess the role of PpmA in pneumococcal adherence, we
examined adherence of all three S. pneumoniae wild-type
strains and their isogenic ppmA-deficient mutants to
human pharyngeal epithelial Detroit 562 cells. Since
previous studies have shown a negative effect of capsule
expression on the adherence ability of S. pneumoniae
(Bootsma et al., 2007; Hammerschmidt et al., 2005; Magee
& Yother, 2001; Selinger & Reed, 1979; Talbot et al., 1996),
we used non-encapsulated derivatives of all strains except
NCTCC10319, which has a very low intrinsic level of
capsule expression. In this way, all PpmA-expressing
strains showed comparable levels of adherence (approx.
105 c.f.u., data not shown). For the NCTC10319 and
TIGR4 strains, a significant decrease in adherence of the
L. E. Cron and others
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DppmA mutants relative to wild-type was observed, namely
41% and 47% reduction, respectively (Fig. 3).
Interestingly, no effect of the ppmA deletion was observed
in the D39 background, suggesting that the contribution of
PpmA to adherence is strain-specific.
Effects of PpmA on pneumococcal host-protein
binding
Various host proteins derived from the extracellular matrix
or serum are potential binding targets for S. pneumoniae,
such as factor H and the secretory component (SC) of the
Fig. 1. Single infection: mouse colonization model. Bacterial
loads in the nasopharyngeal lavage fluid of mice intranasally
infected with (a) D39 wild-type or D39DppmA, (b) TIGR4 wild-
type or TIGR4DppmA, and (c) NCTC10319 wild-type or
NCTC10319DppmA. Five or six animals per group were used,
with the following exceptions: NCTC10319 wild-type at t548 h
(n54) and NCTC10319DppmA at t596 h (n54). The dashed
lines represent the lower limit of detection. *, P,0.05.
Fig. 2. Co-infection: mouse colonization model. Female CD-1
mice were infected intranasally with a 1 : 1 mix of (a) D39
streptomycin-resistant wild-type and D39DppmA, (b) TIGR4
streptomycin-resistant wild-type and TIGR4DppmA or (c)
NCTC10319 streptomycin-resistant wild-type and
NCTC10319DppmA. Data from only two mice are given for
NCTC10319 at t5192 h since no bacteria were found for either
wild-type or ppmA mutant in the other four mice. Each dot
represents one mouse. *, P,0.05.
PpmA of Streptococcus pneumoniae
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human polymeric immunoglobulin receptor (hpIgR). To
assess whether deficiency in ppmA affects the interaction of
pneumococcal surface proteins with these cellular receptors
or host proteins, we investigated the binding of S.
pneumoniae NCTC10319 and its isogenic ppmA mutant to
various immobilized extracellular matrix proteins. The
pneumococcal mutant lacking ppmA bound equally well to
laminin, fibronectin, fibrinogen, lactoferrin, type IV col-
lagen, plasminogen, serum IgA, human secretory compon-
ent and reconstituted basement membrane (Fig. 4).
Contribution of PpmA to pneumococcal uptake by
host cells in vitro
Phagocytosis by neutrophils and macrophages is an
important process to eliminate bacteria. To investigate
the role of PpmA in this process, we first explored the
interactions between the pneumococcus and human PMNs
by flow cytometry using FITC-labelled D39DcpsDppmA
and NCTC10319DppmA and their respective wild-types.
The ppmA mutants of both D39Dcps and NCTC10319
demonstrated a significantly increased association with
human PMNs compared to their isogenic wild-types (Fig.
5a; P-values of 0.001 and 0.043, respectively). Next, we
examined the effect of PpmA on pneumococcal uptake by
murine J774 professional phagocytes. A significant increase
in the amount of internalized D39DcpsDppmA compared to
D39Dcps was measured (Fig. 5b; P-value of 0.0004).
However, no significant difference in uptake between the
NCTC10319 wild-type or TIGR4Dcps and their respective
Fig. 3. In vitro adherence of pneumococcal strains to the human
pharyngeal epithelial cell line Detroit 562. The adherence of the
mutants is given as a percentage relative to the wild-type. *,
P,0.001.
Fig. 4. Effect of ppmA deletion on host-protein binding by
pneumococci. Binding of FITC-labelled S. pneumoniae
NCTC10319 and its isogenic ppmA mutant was assayed to
immobilized host factors (Lm, laminin; Fn, fibronectin; Fbg,
fibrinogen; Lf, lactoferrin; Col, type IV collagen; Plg, plasminogen;
IgA, serum IgA; SC, human secretory component; BM, Matrigel;
and BSA, bovine serum albumin).
Fig. 5. Internalization and killing of ppmA-deficient pneumococci
by PMNs and J774 macrophages. (a) Uptake of FITC-labelled
pneumococci by PMNs. (b) Internalization of pneumococci by
J774 macrophages. (c) Killing of pneumococci by J774 macro-
phages. *, P,0.005.
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DppmA mutants by J774 cells was observed. To determine
whether the observed difference is indeed due to increased
uptake of the ppmA mutant, and not the result of enhanced
killing of intracellular wild-type, we examined intracellular
survival using longer incubation periods of the bacteria and
macrophages. This showed that the observed difference is
indeed caused by enhanced uptake of D39DppmA, as the
rate of intracellular killing of wild-type and mutant was
the same over time, with a mean of 5.3-fold per hour
(Fig. 5c).
DISCUSSION
Nasopharyngeal colonization is a prerequisite for the
development of pneumococcal disease. Colonization and
subsequent invasive infection of S. pneumoniae is depen-
dent on the presence of various proteins targeting host
components, such as pneumococcal surface adhesin A
(PsaA) (Dintilhac et al., 1997; Romero-Steiner et al., 2003),
pneumococcal adherence and virulence factor A (PavA)
(Holmes et al., 2001; Lau et al., 2001) and PspC (Elm et al.,
2004; Hammerschmidt et al., 2000; Rosenow et al., 1997;
Zhang et al., 2000). Proper and efficient folding of such
translocated or secreted proteins is crucial for their
biochemical function and contribution to pneumococcal
pathogenesis. PPIases are ubiquitous protein foldases,
which have been shown to be required for virulence in
various micro-organisms, such as L. pneumophila and S.
pyogenes (Cianciotto et al., 1989; Cianciotto & Fields, 1992;
Lyon et al., 1998). S. pneumoniae produces two surface-
associated PPIases, the lipoproteins SlrA and PpmA.
Previously, we showed SlrA to be a functional cyclophilin
contributing to the early stages of pneumococcal infection
(Hermans et al., 2006). In this study, we examined the role
of PpmA in pneumococcal virulence.
Our results clearly demonstrate that PpmA is involved in
the early stages of the infection process in a strain-specific
manner. The colonization ability of D39DppmA and
TIGR4DppmA was found to be severely reduced compared
to the wild-type strains in both single and co-infection
models. However, even though deletion of ppmA in the
NCTC10319 strain resulted in lower levels of colonization
compared to its wild-type, the difference was not
statistically significant. The NCTC10319 strain was a poor
colonizer of the mouse nasopharynx, which interferes with
appropriate colonization read-out over time. Contributing
to the poor colonization ability of NCTC10319 could be
the fact that it produces very low amounts of capsule
compared to the other two strains (Hammerschmidt et al.,
2005). By testing defined mutants of the capsule locus,
Magee & Yother (2001) demonstrated that expression of a
certain amount of capsule is required for efficient in vivo
colonization. In line with this, pneumococci are known to
undergo spontaneous phase variation, resulting in opaque
and transparent colony variants that are characterized by
high or low levels of capsule, respectively. Enhanced
colonization and adherence are typically seen with the
transparent phase variants, possibly by allowing better
exposure to surface proteins that are important for
adherence (Kim & Weiser, 1998; Weiser et al., 1994).
Furthermore, Briles et al. (2005) showed that mucosal
tissues of mice support both the transparent and opaque
populations of pneumococci. They hypothesized that local
nasal mucosa may be required for maintenance of long-
term carriage and by way of spontaneous phase shift,
pneumococci create a reservoir in the mucosa giving
sufficient opportunity to repopulate the nasal surface over
time (Briles et al., 2005). Interestingly, PpmA was shown to
be more prevalent in the transparent phenotype that is
selected for during nasopharyngeal colonization (Overweg
et al., 2000b).
Since adherence of S. pneumoniae is a prerequisite for
successful colonization, it is likely that the observed role of
PpmA in colonization is at least partially due to its
contribution to adherence. The significant reduction in
adherence observed with ppmA-deficient mutants of
NCTC10319 and TIGR4 compared to their respective
wild-type strains supports this hypothesis. However, no
difference with the ppmA mutant was seen in the D39
background. This apparent discrepancy could, at least partly,
be related to host-specific characteristics, i.e. differences
between murine (in vivo colonization) and human (in vitro
adherence) epithelial cells. S. pneumoniae binds via surface-
located adhesins to various extracellular matrix and serum
proteins, for example lactoferrin (Hammerschmidt et al.,
1999), plasmin(ogen) (Bergmann et al., 2001, 2003, 2004)
and immobilized fibronectin (Holmes et al., 2001; van der
Flier et al., 1995). These adhesins and interactions have been
shown to be involved in pneumococcal pathogenesis
(Bergmann et al., 2003; Holmes et al., 2001; Shaper et al.,
2004). However, our results indicate that PpmA does not
contribute to the interactions of the pneumococcus with any
of the aforementioned factors of the extracellular matrix and
serum. Nonetheless, the effect of PpmA on adherence could
still be mediated through host receptor/protein(s) not tested
in this study.
Once colonization has been established, pneumococci can
replicate and evade the defence mechanisms of the host’s
immune system. Macrophages and PMNs are essential
players in eliminating bacterial infections. Significantly
increased uptake by mouse J774 macrophages and human
PMNs was seen with the D39DppmA mutant compared to
the wild-type, whereas the deletion of ppmA did not affect
uptake in the TIGR4 background. No difference between
intracellular killing of the D39 wild-type and ppmA mutant
was observed. Our data suggest that in addition to
colonization, PpmA contributes to immune evasion by
preventing recognition and uptake by the macrophages at
least in a D39 background.
PPIases are known to catalyse the cis–trans isomerization of
peptidyl-prolyl bonds in vitro, but the physiological
function of many of them is still unknown. The effects
resulting from PPIase mutational inactivation can range
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from severe defects (Dartigalongue & Raina, 1998; Lu et al.,
1996) to none (Dolinski et al., 1997). Our data indicate
that PpmA has a role in adherence, possibly by altering the
surface composition of other bacterial surface proteins and
adhesins that are involved in this process. In addition, the
presence of PpmA appears to protect the pneumococcus
against phagocytosis. So far, presumed pneumococcal
protein target(s) of PpmA remain unknown and are the
subject of current investigation. Because no PPIase activity
has been detected for PpmA (Hermans et al., 2006), it is
plausible that PpmA has evolved from a parvulin-like
ancestor to perform functions other than peptidyl-prolyl
isomerization.
The amino acid sequence of PpmA is conserved among
strains, suggesting that not PpmA itself but the presumed
target(s) of PpmA act in a strain-specific manner. Strain
specificity of pneumococcal virulence factors has been
described before. More than a decade ago it was
demonstrated that the degree of protection of mice
immunized with a pneumolysin toxoid derivative and
subsequently challenged with various serotypes differs
between strains (Alexander et al., 1994). Furthermore, in
a study examining pneumococcal invasion of epithelial
cells, where several hpIgR-expressing cell lines were used
along with various non-encapsulated and encapsulated S.
pneumoniae strains, the hpIgR-dependent invasion of
epithelial cells by S. pneumoniae was both strain-specific
and host cell type-specific (Brock et al., 2002). Finally,
strain specificity is also present at the level of regulation of
gene expression. For instance, the contribution to virulence
of response regulator 09 (RR09) was found to vary between
strains and routes of infection (Blue & Mitchell, 2003). In
line with this, Hendriksen et al. (2007) demonstrated
strain-specific regulation of gene expression by RR09 when
comparing D39 and TIGR4.
Alternatively, the targets of PpmA could differ between
strains. The genomes of D39 and TIGR4 differ by
approximately 10% of their genes (Hakenbeck et al.,
2001). Several of these loci are surface-exposed and/or
related to pathogenesis, and these differences may contrib-
ute to the diversity in virulence seen in animal infection
models (Lanie et al., 2007; Tettelin et al., 2001). A
prominent example is the rlrA pathogenicity islet, which
is found in TIGR4 but not D39. The pilus encoded by this
islet has been shown to contribute to colonization and
invasive disease in vivo as well as adherence in vitro when
using encapsulated strains (Barocchi et al., 2006). Whether
any of these strain-specific loci actually are targets of PpmA
and as such contribute to the differences observed in our
study remains to be investigated.
In summary, we have demonstrated that PpmA has a role
in pneumococcal pathogenesis in a murine colonization
infection model. Altogether, the data suggest that the
contribution of PpmA to colonization is not exclusively
attributable to its role in adherence, but also to its role in
preventing phagocytosis.
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